Impact of the new TNM Staging System (8th edition) on oral tongue cancers.


Journal

Swiss medical weekly
ISSN: 1424-3997
Titre abrégé: Swiss Med Wkly
Pays: Switzerland
ID NLM: 100970884

Informations de publication

Date de publication:
12 04 2021
Historique:
entrez: 2 5 2021
pubmed: 3 5 2021
medline: 21 10 2021
Statut: epublish

Résumé

For tumours of the oral tongue, the most recent 8th edition of the AJCC/UICC staging system has introduced depth of infiltration (DOI) as a novel parameter. With this study we wanted to investigate its impact regarding this risk stratification compared with the preceding 7th edition. Between 2008 and 2017, 161 patients of two tertiary referral centres in Switzerland (Kantonsspital St. Gallen and University Hospital Zurich) with T1 N0 or T2 N0 tongue cancers were enrolled in this study. The primary tumours were restaged according to the 8th edition of the TNM classification. Kaplan-Meier curves for overall and disease-specific survival were calculated. According to the 7th edition, of the 161 patients, 102 were staged after surgery as pT1 (stage I) and 59 as pT2 (stage II). According to the 8th edition, 36 patients (22.4%) were re-staged to a higher stage. Of these 36 patients, 8 (22.2%) experienced a recurrence, and 9 (25%) died. In the remaining, not re-staged group, 20 patients (16.0%) experienced a recurrence (p = 0.55) and 14 (11.2%) died (p = 0.025*). The 7th edition showed a statistically significant difference between pT1 and pT2 tumours for overall survival (p = 0.025), but not for disease-specific survival (p = 0.091), whereas the 8th edition was able to well discriminate between pT1, pT2 and pT3 for both overall (pT1 vs pT2, p = 0.016*; pT2 vs pT3, p = 0.031*) and disease-specific survival (pT1 vs pT2, p = 0.037*; pT2 vs pT3, p = 0.023*). The recent TNM 8th edition provides a more accurate prediction of overall and disease-specific survival for this subgroup of patients. Hence, a more aggressive treatment should be considered for patients re-staged to pT3 due to depth of infiltration.

Identifiants

pubmed: 33934314
doi: 10.4414/smw.2021.20493
pii: Swiss Med Wkly. 2021;151:w20493
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

w20493

Auteurs

Yanic Ammann (Y)

Klinik für Hals-Nasen-Ohrenheilkunde, Kantonsspital St. Gallen, Switzerland / Klinik für Chirurgie, Kantonsspital St. Gallen, Switzerland.

Ulrich Beutner (U)

Klinik für Chirurgie, Kantonsspital St. Gallen, Switzerland.

Domenic Gian Vital (DG)

Klinik für Ohren-, Nasen und Halschirurgie, Universitätsspital Zürich, Switzerland.

Grégoire Morand (G)

Klinik für Ohren-, Nasen und Halschirurgie, Universitätsspital Zürich, Switzerland.

Martina A Broglie Daeppen (MA)

Klinik für Ohren-, Nasen und Halschirurgie, Universitätsspital Zürich, Switzerland.

Diana Born (D)

Klinik für Pathologie, Kantonsspital St. Gallen, Switzerland.

Sandro J Stoeckli (SJ)

Klinik für Hals-Nasen-Ohrenheilkunde, Kantonsspital St. Gallen, Switzerland.

Gerhard F Huber (GF)

Klinik für Hals-Nasen-Ohrenheilkunde, Kantonsspital St. Gallen, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH